Sensei Biotherapeutics earnings were -$29.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SNSE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.9M, down 11.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNSE reported annual earnings of -$30.2M, with -11.6% growth.
Sensei Biotherapeutics Earnings Reports & History FAQ
What were Sensei Biotherapeutics's earnings last quarter?
On SNSE's earnings call on Invalid Date, Sensei Biotherapeutics (NASDAQ: SNSE) reported Q1 2025 earnings per share (EPS) of -$0.27, up 15.63% year over year. Total SNSE earnings for the quarter were -$6.86 million. In the same quarter last year, Sensei Biotherapeutics's earnings per share (EPS) was -$0.32.
Is Sensei Biotherapeutics profitable or losing money?
As of the last Sensei Biotherapeutics earnings report, Sensei Biotherapeutics is currently losing money. Sensei Biotherapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$29.03 million, a 9.05% decrease year over year.
What was SNSE's earnings growth in the past year?
As of Sensei Biotherapeutics's earnings date in Invalid Date, Sensei Biotherapeutics's earnings has grown year over year. SNSE earnings in the past year totalled -$29.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.